Preparation method and application of HPV (human papillomavirus) rapid detection reagent
By combining magnetic nanoparticles and platinum nanoparticle catalytic materials with the CRISPR-Cas13a system, the problems of low pre-treatment efficiency and cumbersome detection steps caused by the complex sample matrix in HPV virus detection are solved, and efficient and portable viral RNA rapid detection is achieved, which is suitable for POCT applications.
Patent Information
- Application Number
- CN202510966959.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-07-14
- Publication Date
- 2025-10-14
AI Technical Summary
Existing HPV virus detection technology has low pre-treatment efficiency when faced with complex sample matrices, and the differences in amplification and detection incubation temperatures lead to cumbersome steps. In addition, the functions and flow dynamics of microfluidic chips are limited, making it difficult to achieve portable and efficient detection.
Magnetic nanoparticles combined with platinum nanoparticle catalytic materials are used to quickly separate HPV viral RNA through magnetic separation technology. The catalytic activity of platinum nanoparticles is used to drive the flow of fluid in the microfluidic chip. Combined with the CRISPR-Cas13a system, signal amplification and detection are achieved, and rapid detection is performed using a microfluidic disc chip.
It achieves efficient enrichment of low-copy viruses in complex samples, improves detection sensitivity and accuracy, simplifies operating procedures, reduces costs, and improves portability, making it suitable for POCT testing.